Loading…
Clinical Features of Hemophagocytic Syndrome in Patients with Dermatomyositis
Objective To investigate the clinical features of patients with dermatomyositis (DM) complicated by hemophagocytic syndrome (HPS). Methods Twenty-four patients diagnosed with DM and treated at our hospital between January 2002 and April 2007 were enrolled for study. Serum levels of various parameter...
Saved in:
Published in: | Journal of rheumatology 2008-09, Vol.35 (9), p.1838-1841 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective
To investigate the clinical features of patients with dermatomyositis (DM) complicated by hemophagocytic syndrome (HPS).
Methods
Twenty-four patients diagnosed with DM and treated at our hospital between January 2002 and April 2007 were enrolled for study.
Serum levels of various parameters including cytokines were determined during the active disease states.
Results
Levels of serum ferritin, creatine kinase, and immune complexes were all significantly higher in all patients with HPS than
in those without HPS. Levels of soluble interleukin-2 receptor, macrophage colony stimulating factor, and the chemokine CX3CL1
were significantly elevated in DM patients with HPS.
Conclusion
Our findings suggest that mechanisms related to both circulating immune complexes and circulating cytokines are involved in
the pathogenesis of HPS complicating DM.
Key Indexing Terms:
HEMOPHAGOCYTIC SYNDROME
DERMATOMYOSITIS
CYTOKINE
CX3CL1 |
---|---|
ISSN: | 0315-162X 1499-2752 |